These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 18304585)
1. Predominant role of 25OHD in the negative regulation of PTH expression: clinical relevance for hypovitaminosis D. Kawahara M; Iwasaki Y; Sakaguchi K; Taguchi T; Nishiyama M; Nigawara T; Tsugita M; Kambayashi M; Suda T; Hashimoto K Life Sci; 2008 Mar; 82(13-14):677-83. PubMed ID: 18304585 [TBL] [Abstract][Full Text] [Related]
2. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells. Segersten U; Björklund P; Hellman P; Akerström G; Westin G Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875 [TBL] [Abstract][Full Text] [Related]
3. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells. Brown AJ; Ritter CS; Knutson JC; Strugnell SA Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703 [TBL] [Abstract][Full Text] [Related]
4. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549 [TBL] [Abstract][Full Text] [Related]
5. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772 [TBL] [Abstract][Full Text] [Related]
6. Involvement of GCMB in the transcriptional regulation of the human parathyroid hormone gene in a parathyroid-derived cell line PT-r: effects of calcium and 1,25(OH)2D3. Kawahara M; Iwasaki Y; Sakaguchi K; Taguchi T; Nishiyama M; Nigawara T; Kambayashi M; Sawada T; Jing X; Miyajima M; Terada Y; Hashimoto K; Suda T Bone; 2010 Sep; 47(3):534-41. PubMed ID: 20558332 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies. Passeri E; Bugiardini E; Sansone VA; Valaperta R; Costa E; Ambrosi B; Meola G; Corbetta S J Neurol Sci; 2013 Aug; 331(1-2):132-5. PubMed ID: 23809192 [TBL] [Abstract][Full Text] [Related]
8. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Boudville NC; Hodsman AB Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777 [TBL] [Abstract][Full Text] [Related]
9. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136 [TBL] [Abstract][Full Text] [Related]
10. Relationship between 25-hydroxyvitamin D concentrations, serum calcium, and parathyroid hormone in apparently healthy Syrian people. Sayed-Hassan R; Abazid N; Alourfi Z Arch Osteoporos; 2014; 9():176. PubMed ID: 24715441 [TBL] [Abstract][Full Text] [Related]
11. Relationship between serum 25-hydroxyvitamin D and parathyroid hormone in the search for a biochemical definition of vitamin D deficiency in children. Atapattu N; Shaw N; Högler W Pediatr Res; 2013 Nov; 74(5):552-6. PubMed ID: 23999068 [TBL] [Abstract][Full Text] [Related]
12. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. St-Arnaud R; Messerlian S; Moir JM; Omdahl JL; Glorieux FH J Bone Miner Res; 1997 Oct; 12(10):1552-9. PubMed ID: 9333115 [TBL] [Abstract][Full Text] [Related]
13. Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Chen JS; Sambrook PN; March L; Cameron ID; Cumming RG; Simpson JM; Seibel MJ Clin Endocrinol (Oxf); 2008 Feb; 68(2):290-8. PubMed ID: 17854393 [TBL] [Abstract][Full Text] [Related]
14. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients? Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930 [TBL] [Abstract][Full Text] [Related]
16. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism. Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090 [TBL] [Abstract][Full Text] [Related]
17. Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart Defects. Passeri E; Rigolini R; Costa E; Verdelli C; Arcidiacono C; Carminati M; Corbetta S Dis Markers; 2016; 2016():3970284. PubMed ID: 26955207 [TBL] [Abstract][Full Text] [Related]
18. 25-hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidism. Adler JT; Sippel RS; Chen H Ann Surg Oncol; 2010 Nov; 17(11):2958-62. PubMed ID: 20544293 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D status regulates 25-hydroxyvitamin D3-1 alpha-hydroxylase and its responsiveness to parathyroid hormone in the chick. Booth BE; Tsai HC; Morris RC J Clin Invest; 1985 Jan; 75(1):155-61. PubMed ID: 4038405 [TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]